Journal of Inflammation Research, 2025
Development of Predictive Models for Long-Term Endoscopic Response to Ustekinumab in Crohn’s Disease Based on Plasma Proteomics

Wu C., Zheng J., Qian X. et al.

Journal of Thoracic Disease, 2025
Postoperative innate immune function after minimally invasive transcervical esophagectomy (MICE) versus minimally invasive transthoracic esophagectomy (MIE)

Jacobs L., Drager L., Joosten L. et al.

Critical Public Health, 2025
Causal relationships between plasma protein ratios and lung cancer risk: a Mendelian randomization study

Zhang P., Chen Y., Yao L. et al.

Journal for ImmunoTherapy of Cancer, 2025
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer

Wang X., Ricciuti B., Elkrief A. et al.

JCI Insight, 2025
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis

Strawn D., Krueger J., Bissonnette R. et al.

Cytokine, 2025
Associations between plasma ANGPTL4 levels and the risk of 24 cancers: a prospective cohort study

Cheng X., Zhao S., Du M. et al.

Hepatology Research, 2025
Plasma Vascular Endothelial Growth Factor‐A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Tajima K., Miuma S., Sasaki R. et al.

Journal of the Endocrine Society, 2025
Urinary Proteomics as a Noninvasive Readout of Obesity-associated Inflammation

Canki E., Kho E., van Stiphout R. et al.

Cancer Immunology, Immunotherapy, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Changoer P., Peng C., van Houten P. et al.

Pancreas, 2025
Plasma Proteomics Identifies Potential Pancreatic Cancer Risk Indicators in Type 2 Diabetes

Chu S., Liu J., Liu X. et al.

International Journal of Molecular Sciences, 2025
Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

González-Montero M., Andrés-Rodríguez J., Criado M. et al.

Circulation, 2025
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Hundertmark M., Birkhoelzer S., Portwood C. et al.

PLOS One, 2025
Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study “No One Alone-Gesida Study”

Blanco J., Albendin-Iglesias H., Negredo-Puigmal E. et al.

Inflammatory Bowel Diseases, 2025
Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn’s Disease and Ulcerative Colitis

Gan X., Zhang Y., Zhang Y. et al.

BMJ Neurology Open, 2025
Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteome

Akel S., Ashtiani S., Sarangdhar M. et al.

International Journal of Cardiology, 2025
The association between collagen 1a1, NTproBNP and echocardiographic markers in patients with or at risk of HFpEF

Rastogi T., Kobayashi M., Ferreira J. et al.

Medicine, 2025
A two-sample Mendelian randomization analysis of the impact of GABA receptor subtypes on human height

Chen L., Zeng Z., Wu M. et al.

Medicine, 2025
Identification of therapeutic targets for insomnia through genetic and plasma proteomic approaches

Wang X., Lu J., Lin F. et al.

Acta Neuropathologica Communications, 2025
Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival

Bentivenga G., Mammana A., Gogishvili D. et al.

Journal of the European Academy of Dermatology and Venereology, 2025
High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid

Calabrese L., Vallini G., Bonacchi L. et al.